Inside Look: Lexitas’ Best Corrected Visual Acuity Certification Program
Lexitas’ Best Corrected Visual Acuity Certification program, powered by Pro-ficiency’s virtual simulation technology, is a best-in-class solution for training and recertification of visual acuity testing. In this video, Dr. Sally Tucker and Dr. Andrew Pucker discuss visual acuity testing in clinical trials, how the Lexitas BCVA program was developed, and the types of trials that […]
Read MoreHow Allgenesis Evaluated Unique Endpoints to Advance its Phase
In this webinar, Sally Tucker, President of Global Services for Lexitas, is joined by the leadership team of Voxeleron and Allgenesis to discuss their collaboration on a recent phase two study for diabetic macular edema (DME). The panelists highlight the importance of imaging and biomarkers in ophthalmology clinical trials and share their experiences working with […]
Read MoreFrom Patient Care to Research: Dr. Bruce Segal’s Journey
Welcome back to the InFocus podcast series, hosted by Dr. Andrew Pucker, Senior Director of Clinical Medical Sciences at Lexitas Pharma Surfaces. In this episode, Dr. Pucker sits down with Dr. Bruce Segal, an experienced ophthalmologist based in Delray Beach, Florida, to delve into the world of medical research. Dr. Segal shares his journey into […]
Read MoreThe Impact of Contact Lens Wear On the Ocular Surface w/ Dr. Joe Shovlin
In this episode of the Infocus podcast series, host Dr. Andrew Pucker is joined by Dr. Joe Shovlin to discuss the impact of contact lenses on the ocular surface. The conversation revolves around a paper from the Tear Film and Ocular Surface Society (TFOS) titled “Impact of Contact Lenses on the Ocular Surface” and its […]
Read MoreLifestyle Impact On Ocular Health w/ Dr. Sheetal Shah
In this episode of the “In Focus” podcast series, Dr. Sheetal Shah, Cornea and External Disease Specialist sits with Dr. Andrew Pucker, Senior Director of Clinical Medical Science at Lexitas Pharma Services to discuss the impact of cosmetics on the ocular surface. They delve into the findings of the Tear Film and Ocular Surface Society’s […]
Read MoreHow Exonate Plans to Revolutionize Diabetic Eye Disease Treatment: A Convo with Dr. Catherine Beech
In this episode of “In Focus,” Julie Schlosser sits down with Dr. Catherine Beech, CEO of biotech company Exonate, to discuss their cutting-edge work in ophthalmology. Exonate is focused on developing a groundbreaking eye drop treatment for diabetic eye disease, aiming to replace the need for invasive injections into the eye. Dr. Beech shares the […]
Read MoreTrends in Ophthalmology Clinical Trials (Video)
Ophthalmic clinical trials are increasing in complexity, as novel endpoints, new innovations in gene therapy and advances in AI are helping to push the boundaries of what was previously possible. Listen to CRO experts in clinical operations and ophthalmology talk about the trends and opportunities in clinical studies for eye disease. Our In Focus newsletter is published […]
Read MoreThe State of the Ophthalmology Funding Landscape
Lexitas Pharma Services CEO and Executive Chairwoman Jeanne Hecht joins Triangle Business Journal President and Publisher Jason Christie to talk about Lexitas’ recent growth and where it’s headed as the new year approaches. See More Our In Focus newsletter is published once a month and has thousands of subscribers. To help you keep in touch, you can subscribe […]
Read More